<DOC>
	<DOCNO>NCT00668200</DOCNO>
	<brief_summary>This study evaluate impact investigator patient education educational material foster calcium vitamin D supplementation mitigate potential hypocalcemia post Reclast速 administration patient Paget 's disease bone .</brief_summary>
	<brief_title>Impact Reducing Incidence Low Serum Calcium Providing Educational Materials Need Take Daily Supplemental Calcium Vitamin D Patients With Paget 's Disease Treated With Reclast速</brief_title>
	<detailed_description />
	<mesh_term>Hypocalcemia</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Osteitis Deformans</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Written informed consent As per currently approve Reclast速 Package Insert : As per currently approve Reclast速 Package Insert :</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Paget 's</keyword>
	<keyword>hypocalcemia</keyword>
	<keyword>zoledronic acid</keyword>
	<keyword>serum calcium</keyword>
</DOC>